Macrogenics Form 144 Insider Sale Filing
Macrogenics filed a Form 144 with the Securities and Exchange Commission on 13 July 2026, indicating an intended sale of securities under Rule 144. The filing was made public on 14 July 2026 at 07:04 am, demonstrating compliance with insider‑transaction reporting requirements. The market reaction showed the company’s shares, ticker MGNX, gaining 3.93 % on the day of the announcement. No additional details such as the number of shares, price, or selling parties were disclosed in the filing.